Myriad Genetics, Inc. (NASDAQ:MYGN) Investor Notice: Investigation over Potential Wrongdoing
January 25, 2021 at 12:30 PM EST
San Diego, CA -- (SBWIRE) -- 01/25/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Myriad Genetics, Inc.